GFPT1 and hepatocellular carcinoma: The pharmacological inhibition or knockout of GFAT was found to increase the sensitivity of HCC cells to diamide-induced oxidative stress, indicating that combining targeting at GFAT with the induction of oxidative stress could achieve better therapeutic effects [9].